Christopher W. Moth

Christopher W. Moth

Auto-generated profile, based on publicly available information

Christopher W. Moth

Departments of Chemistry, Pharmacology, and Biomedical Informatics, Center for Structural Biology and Institute of Chemical Biology; Vanderbilt University, Nashville, Tennessee, United States of America

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 April 2024 in Nucleic Acids Research
Verified
Journal Article
Open access
PDF file
MPMichelle Philipp
Michelle Philipp
CMChristopher W Moth
Christopher W Moth
NRNikola Ristic
Nikola Ristic
JTJohanna K S Tiemann
Johanna K S Tiemann
FSFlorian Seufert
Florian Seufert
RSRené Staritzbichler
René Staritzbichler
The possible effects of mutations on stability and function of a protein can only be understood in the context of protein 3D structure. The MutationExplorer webserver maps sequence changes onto protein structures and allows users to study variation by inputting sequence changes. As the user enters variants, the 3D model evolves, and estimated changes in energy are highlighted. In addition to a basic per-residue input format, MutationExplorer can also upload an entire replacement sequence. Previously the purview of desktop applications, such an upload can back-mutate PDB structures to wildtype sequence in a single step. Another supported variation source is human single nucelotide polymorphisms (SNPs), genomic coordinates input in VCF format. Structures are flexibly colorable, not only by energetic differences, but also by hydrophobicity, sequence conservation, or other biochemical profiling. Coloring by interface score reveals mutation impacts on binding surfaces. MutationExplorer strives for efficiency in user experience. For example, we have prepared 45 000 PDB depositions for instant retrieval and initial display. All modeling steps are performed by Rosetta. Visualizations leverage MDsrv/Mol*. MutationExplorer is available at: http://proteinformatics.org/mutation_explorer/.

25 March 2023 in bioRxiv
Verified
Preprint
Open access
PDF file
MPMichelle Philipp
Michelle Philipp
CMChristopher W. Moth
Christopher W. Moth
NRNikola Ristic
Nikola Ristic
JTJohanna K.S. Tiemann
Johanna K.S. Tiemann
FSFlorian Seufert
Florian Seufert
RSRené Staritzbichler
René Staritzbichler
A bstract: The possible effects of mutations on stability and function of a protein can only be understood in the context of protein 3D structure. The M utation E xplorer webserver maps sequence changes onto protein structures and allows users to study variation by inputting sequence changes. As the user enters variants, the 3D model evolves, and estimated changes in energy are highlighted. In addition to a basic per-residue input format, M utation E xplorer can also upload an entire replacement sequence. Previously the purview of desktop applications, such an upload can back-mutate PDB structures to wildtype sequence in a single step. Another supported variation source is human single nucelotide polymorphisms (SNPs), genomic coordinates input in VCF format. Structures are flexibly colorable, not only by energetic differences, but also by hydrophobicity, sequence conservation, or other biochemical profiling. Coloring by interface score reveals mutation impacts on binding surfaces. M utation E xplorer strives for efficiency in user experience. For example, we have prepared 45,000 PDB depositions for instant retrieval and initial display. All modeling steps are performed by Rosetta. Visualizations leverage MDsrv/Mol*. M utation E xplorer is available at: http://proteinformatics.org/mutation_explorer/

4 May 2026 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
CMChristopher W Moth
Christopher W Moth
JSJonathan H Sheehan
Jonathan H Sheehan
AMAbdullah Al Mamun
Abdullah Al Mamun
RSR Michael Sivley
R Michael Sivley
AGAlican Gulsevin
Alican Gulsevin
JMJens Meiler
Jens Meiler
Effective diagnosis and treatment of rare genetic disorders requires the interpretation of a patient’s genetic variants of unknown significance (VUSs). Today, clinical decision-making is primarily guided by gene-phenotype association databases and DNA-based scoring methods. Our web-accessible variant analysis pipeline, VUStruct, supplements these established approaches by deeply analyzing the downstream molecular impact of variation in context of 3D protein structure. VUStruct’s growing impact is fueled by the co-proliferation of protein 3D structural models, gene sequencing, compute power, and artificial intelligence. Contextualizing VUSs in protein 3D structural models also illuminates longitudinal genomics studies and biochemical bench research focused on VUS, and we created VUStruct for clinicians and researchers alike. We now introduce VUStruct to the broad scientific community as a mature, web-facing, extensible, High-Performance Computing (HPC) software pipeline. VUStruct maps missense variants onto automatically selected protein structures and launches a broad range of analyses. These include energy-based assessments of protein folding and stability, pathogenicity prediction through spatial clustering analysis, and machine learning (ML) predictors of binding surface disruptions and nearby post-translational modification sites. The pipeline also considers the entire input set of VUS and identifies genes potentially involved in digenic disease. VUStruct’s utility in clinical rare disease genome interpretation has been demonstrated through its analysis of over 175 Undiagnosed Disease Network (UDN) Patient cases. VUStruct-leveraged hypotheses have often informed clinicians in their consideration of additional patient testing, and we report here details from two cases where VUStruct was key to their solution. We also note successes with academic research collaborators, for whom VUStruct has informed research directions in both computational genomics and wet lab studies.